Bar Harbor Trust Services Novo Nordisk A S Transaction History

Bar Harbor Trust Services

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$103.24 - $121.81 $11.9 Million - $14.1 Million	-115,567 Closed	0 $0
Q1 2022 Apr 14, 2022	BUY	$93.1 - $112.54 $40,219 - $48,617	432 Added 0.38%	115,567 $12.8 Million
Q4 2021 Jan 28, 2022	SELL	$95.88 - $117.08 $287 - $351	-3 Reduced -0.0%	115,135 $12.9 Million
Q3 2021 Nov 15, 2021	SELL	$84.42 - $106.62 $183,529 - $231,791	-2,174 Reduced 1.85%	115,138 $11.1 Million
Q2 2021 Aug 11, 2021	BUY	$67.66 - $84.76 $20,095 - $25,173	297 Added 0.25%	117,312 $9.83 Million
Q1 2021 May 06, 2021	BUY	$67.06 - $75.82 $256,236 - $289,708	3,821 Added 3.38%	117,015 $7.89 Million
Q4 2020 Feb 09, 2021	BUY	$63.89 - $73.8 $293,894 - $339,480	4,600 Added 4.24%	113,194 $7.91 Million
Q3 2020 Nov 02, 2020	BUY	$63.69 - $70.22 $211,196 - $232,849	3,316 Added 3.15%	108,594 $7.54 Million
Q2 2020 Aug 04, 2020	BUY	$58.54 - $67.94 $116,787 - $135,540	1,995 Added 1.93%	105,278 $6.89 Million
Q1 2020 May 14, 2020	BUY	$49.46 - $64.78 $5.11 Million - $6.69 Million	103,283 New	103,283 $6.22 Million

1,991

318M

5.23M

4.97M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $273B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Bar Harbor Trust Services, based on Form 13F filings with the SEC.

Stay updated on Bar Harbor Trust Services with notifications on news.